1. Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis. Issue 1 (7th September 2021) Authors: Naganuma, Makoto; Watanabe, Kenji; Motoya, Satoshi; Ogata, Haruhiko; Matsui, Toshiyuki; Suzuki, Yasuo; Ursos, Lyann; Sakamoto, Shigeru; Shikamura, Mitsuhiro; Hori, Tetsuharu; Fernandez, Jovelle; Watanabe, Mamoru; Hibi, Toshifumi; Kanai, Takanori Other Names: Yu Jun guestEditor. Journal: Journal of gastroenterology and hepatology Issue: Volume 37:Issue 1(2022) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗